Cargando…
Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy
The progression of many solid tumors is driven by de-regulation of multiple common pathways, particularly Rb, PI (3) K/Akt and p53. Prior studies identified TopBP1as a key mediator for the oncogenic gain-of-function activities of mutant p53 (mutp53) in cancer. In Akt-hyperactive cancer, TopBP1 forms...
Autores principales: | Chowdhury, Pinki, Lin, Gregory E., Liu, Kang, Song, Yongcheng, Lin, Fang-Tsyr, Lin, Weei-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254804/ https://www.ncbi.nlm.nih.gov/pubmed/25400145 http://dx.doi.org/10.1038/ncomms6476 |
Ejemplares similares
-
Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer
por: Liu, Kang, et al.
Publicado: (2021) -
Cdks put Treslin on TopBP1
por: Short, Ben
Publicado: (2011) -
Expression of TopBP1 in hereditary breast cancer
por: Forma, Ewa, et al.
Publicado: (2012) -
Cooperative activation of the ATR checkpoint kinase by TopBP1 and damaged DNA
por: Choi, Jun-Hyuk, et al.
Publicado: (2009) -
MDC1 collaborates with TopBP1 in DNA replication checkpoint control
por: Wang, Jiadong, et al.
Publicado: (2011)